The measurement and importance of red cell survival

American Journal of Hematology

Volumn 84, Issue 2, 2009, Pages 109-114

  Franco, Robert S ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; CARBON MONOXIDE; CHROMIUM 51; CYTOKINE; IRON 59; RADIOISOTOPE; TECHNETIUM 99M;

AGGLUTINATION TEST; ANEMIA; BLOOD SAMPLING; BLOOD TRANSFUSION; CELL AGING; CIRCULATION; DIABETES MELLITUS; ERYTHROCYTE LIFESPAN; ERYTHROCYTE PRESERVATION; ERYTHROPOIESIS; FLOW CYTOMETRY; GROUPS BY AGE; HEMAGGLUTINATION; HEMOLYTIC ANEMIA; HUMAN; IRON METABOLISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA;

ANEMIA; ANIMALS; BIOTINYLATION; BREATH TESTS; CARBON MONOXIDE; CHROMIUM ISOTOPES; CHROMIUM RADIOISOTOPES; DIABETES MELLITUS; ERYTHROCYTE AGING; ERYTHROPOIESIS; FLOW CYTOMETRY; HEMAGGLUTINATION TESTS; HEMATOLOGIC DISEASES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFANT, NEWBORN; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; STAINING AND LABELING;

EID: 59949084691     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21298     Document Type: Review

References (77)

1. Kay MM. Senescent cell antigen, band 3, and band 3 mutations in cellular aging. Biomed Biochim Acta 1990;49:S212-S217.
2. Kay MM. Localization of senescent cell antigen on band 3. Proc Natl Acad Sci USA 1984;81:5753-5757.
3. Christian JA, Rebar AH, Boon GD, Low PS. Senescence of canine biotinylated erythrocytes: Increased autologous immunoglobulin binding occurs on erythrocytes aged in vivo for 104 to 110 days. Blood 1993;82:3469-3473.
4. Low PS, Waugh SM, Zinke K, Drenckhahn D. The role of hemoglobin denaturation and band 3 clustering in red blood cell aging. Science 1985;227:531-533.
5. Rettig MP Low PS, Gimm JA, Mohandas N, Wang JZ, Christian JA. Evaluation of biochemical changes during in vivo erythrocyte senescence in the dog. Blood 1999;93:376-384.
6. Rice L, Alfrey CP, Driscoll T, Whitley CE, Hachey DL, Suki W. Neocytolysis contributes to the anemia of renal disease. Am J Kidney Dis 1999;33:59-62.
7. Rice L, Alfrey CP. The negative regulation of red cell mass by neocytolysis: Physiologic and pathophysiologic manifestations. Cell Physiol Biochem 2005;15:245-250.
8. Risso A, Turello M, Biffoni F, Antonutto G. Red blood cell senescence and neocytolysis in humans after high altitude acclimatization. Blood Cells Mol Dis 2007;38:83-92.
9. Boas FE, Forman L, Beutler E. Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc Natl Acad Sci USA 1998;95:3077-3081.
10. Gifford SC, Yoshida T, Shevkoplyas SS, Bitensky MW. A high-resolution, double-labeling method for the study of in vivo red blood cell aging. Transfusion 2006;46:578-588.
11. Zimran A, Forman L, Suzuki T, Dale GL, Beutler E. In vivo aging of red cell enzymes: Study of biotinylated red blood cells in rabbits. Am J Hematol 1990;33:249-254.
12. Willekens FL, Bosch FH, Roerdinkholder-Stoelwinder B, Groenen-Dopp YA, Werre JM. Quantification of loss of haemoglobin components from the circulating red blood cell in vivo. Eur J Haematol 1997;58:246-250.
13. Willekens FL, Roerdinkholder-Stoelwinder B, Groenen-Dopp YA, et al. Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation. Blood 2003;101:747-751.
14. Bosch FH, Werre JM, Roerdinkholder-Stoelwinder B, Huls TH, Willekens FL, Halie MR. Characteristics of red blood cell populations fractionated with a combination of counterfiow centrifugation and Percoll separation. Blood 1992;79:254-260.
15. Waugh RE, McKenney JB, Bauserman RG, Brooks DM, Valeri CR, Snyder LM. Surface area and volume changes during maturation of reticulocytes in the circulation of the baboon. J Lab Clin Med 1997;129:527-535.
16. Dale GL, Norenberg SL. Density fractionation of erythrocytes by percoll/hypaque results in only a slight enrichment for aged cells. Biochim Biophys Acta 1990;1036:183-187.
17. Mueller TJ, Jackson CW, Dockter ME, Morrison M. Membrane skeletal alterations during in vivo mouse red cell aging. Increase in the band 4.1a:4.1b ratio. J Clin Invest 1987;79:492-499.
18. Ravindranath Y, Brohn F, Johnson RM. Erythrocyte age-dependent changes of membrane protein 4.1: Studies in transient erythroblastopenia. Pediatr Res 1987;21:275-278.
19. Sauberman N, Fortier NL, Fairbanks G, O'Connor RJ, Snyder LM. Red cell membrane in hemolytic disease. Studies on variabes affecting electrophoretic analysis. Biochim Biophys Acta 1979;556:292-313.
20. Lutz HU, Stammler P, Fasler S, Ingold M, Fehr J. Density separation of human red blood cells on self forming Percoll gradients: Correlation with cell age. Biochim Biophys Acta 1992;1116:1-10.
21. Fehr J, Knob M. Comparison of red cell creatine level and reticulocyte count in appraising the severity of hemolytic processes. Blood 1979;53: 966-976.
22. Maccormick VM, Hill LM, Macneil L, Burke DG, Smith-Palmer T. Elevation of creatine in red blood cells in vegetarians and nonvegetarians after creatine supplementation. Can J Appl Physiol 2004;29:704-713.
23. Khandelwal S, Saxena RK. Assessment of survival of aging erythrocyte in circulation and attendant changes in size and CD147 expression by a novel two step biotinylation method. Exp Gerontol 2006;41:855-861.
24. Ashby W. The determination of the length of life of transfused blood corpuscles in man. J Exp Med 1919;29:267-281.
25. Ashby W. Study of transfused Blood. I. The periodicity in eliminative activity shown by the organism. J Exp Med 1921;34:127-146.
26. Ashby W. Study of transfused blood. II. Blood destruction in pernicious anemia. J Exp Med 1921;34:147-166.
27. Gray SJ, Sterling K. Determination of circulating red cell volume by radioactive chromium. Science 1950;112:179-180.
28. Ebaugh FG Jr, Emerson CP, Ross JF. The use of radioactive chromium 51 as an erythrocyte tagging agent for the determination or red cell survival in vivo. J Clin Invest 1953;32:1260-1276.
29. Recommended method for radioisotope red-cell survival studies. International Committee for Standardization in Haematology. Br J Haematol 1980;45:659-666.
30. Bentley SA, Glass HI, Lewis SM, Szur L. Elution correction in 51Cr red cell survival studies. Br J Haematol 1974;26:179-184.
31. Cline MJ, Berlin NI. The red cell chromium elution rate in patients with some hematologic diseases. Blood 1963;21:63-69.
32. Heaton WA, Keegan T, Hanbury CM, Holme S, Pleban P. Studies with nonradioisotopic sodium chromate. II. Single- and double-label 52Cr/51Cr post- transfusion recovery estimations. Transfusion 1989;29:703-707.
33. Heaton WA, Hanbury CM, Keegan TE, Pleban P, Holme S. Studies with nonradioisotopic sodium chromate. I. Development of a technique for measuring red cell volume. Transfusion 1989;29:696-702.
34. Silver HM, Seebeck MA, Cowett RM, Patterson KY, Veillon C. Red cell volume determination using a stable isotope of chromium. J Soc Gynecol Investig 1997;4:254-258.
35. Sioufi HA, Button LN, Jacobson MS, Kevy SV. Nonradioactive chromium technique for red cell labeling. Vox Sang 1990;58:204-206.
36. Coburn RF, Williams WJ, Kahn SB. Endogenous carbon monoxide production in patients with hemolytic anemia. J Clin Invest 1966;45:460-468.
37. Coburn RF. Endogenous carbon monoxide production. N Engl J Med 1970;282:207-209.
38. Coburn RF, Blakemore WS, Forster RE. Endogenous carbon monoxide production in man. J Clin Invest 1963;42:1172-1178.
39. Bensinger TA, Brouillard RP, Conrad ME. Endogenous production of carbon monoxide as measured simultaneously in blood and gas phase. Br J Haematol 1975;29:487-494.
40. Logue GL, Rosse WF, Smith WT, Saltzman HA, Gutterman LA. Endogenous carbon monoxide production measured by gas-phase analysis: An estimation of heme catabolic rate. J Lab Clin Med 1971;77:867-876.
41. Solanki DL, McCurdy PR, Cuttitta FF, Schechter GP. Hemolysis in sickle cell disease as measured by endogenous carbon monoxide production. A preliminary report. Am J Clin Pathol 1988;89:221-225.
42. Furne JK, Springfield JR, Ho SB, Levitt MD. Simplification of the end-alveolar carbon monoxide technique to assess erythrocyte survival. J Lab Clin Med 2003;142:52-57.
43. Strocchi A, Schwartz S, Ellefson M, Engel RR, Medina A, Levitt MD. A simple carbon monoxide breath test to estimate erythrocyte turnover. J Lab Clin Med 1992;120:392-399.
44. Mitlyng BL, Chandrashekhar Y, Furne JK, Levitt MD. Use of breath carbon monoxide to measure the influence of prosthetic heart valves on erythrocyte survival. Am J Cardiol 2006;97:1374-1376.
45. Dale GL, Daniels RB. Quantitation of immunoglobulin associated with senescent erythrocytes from the rabbit. Blood 1991;77:1096-1099.
46. Suzuki T, Dale GL. Senescent erythrocytes: Isolation of in vivo aged cells and their biochemical characteristics. Proc Natl Acad Sci 1988;85:1647-1651.
47. Suzuki T, Dale GL. Membrane proteins in senescent erythrocytes. Biochem J 1989;257:37-41.
48. Suzuki T, Dale GL. Biotinylated erythrocytes: In vivo survival and in vitro recovery. Blood 1987;70:791-795.
49. Waugh RE, Narla M, Jackson CW, Mueller TJ, Suzuki T, Dale GL. Rheologic properties of senescent erythrocytes: Loss of surface area and volume with red blood cell age. Blood 1992;79:1351-1358.
50. Hoffman-Fezer G, Maschke H, Zeitler HJ, Gais P, Heger W, Ellwart J, Thierfelder S. Direct in vivo biotinylation of erythrocytes as an assay for red cell survival studies. Ann Hematol 1991;63:214-217.
51. Hoffman-Fezwe G, Mysliwietz J, Mortlbauer W, et al. Biotin labeling as an alternative nonradioactive approach to determination of red cell survival. Ann Hematol 1993;67:81-87.
52. Franco RS, Lohmann J, Silberstein EB, et al. Time-dependent changes in the density and hemoglobin F content of biotin-labeled sickle cells. J Clin Invest 1998;101:2730-2740.
53. Franco RS, Yasin Z, Lohmann JM, et al. The survival characteristics of dense sickle cells. Blood 2000;96:3610-3617.
54. Franco RS, Yasin Z, Palascak MB, Ciraolo P, Joiner CH, Rucknagel DL. The effect of fetal hemoglobin on the survival characteristics of sickle cells. Blood 2006;108:1073-1076.
55. Yasin Z, Witting S, Palascak MB, Joiner CH, Rucknagel DL, Franco RS. Phosphatidylserine externalization in sickle red blood cells: Associations with cell age, density, and hemoglobin F. Blood 2003;102:365-370.
56. Cordle DG, Strauss RG, Lankford G, Mock DM. Antibodies provoked by the transfusion of biotin-labeled red cells. Transfusion 1999;39:1065-1069.
57. 51Cr-labeled red cells. Transfusion 1999;39:156-162.
58. Strauss RG, Mock DM, Widness JA, Johnson K, Cress G, Schmidt RL. Posttransfusion 24-hour recovery and subsequent survival of allogeneic red blood cells in the bloodstream of newborn infants. Transfusion 2004;44:871-876.
59. Cavill I, Trevett D, Fisher J, Hoy T. The measurement of the total volume of red cells in man: A non-radioactive approach using biotin. Br J Haematol 1988;70:491-493.
60. Hudson IRB, Cavill IAJ, Cooke A, et al. Biotin labeling of red cells in the measurement of red cell volume in preterm infants. Pediatr Res 1990;28:199-202.
61. Cohen RM, Franco RS, Khera PK, et al. Red cell lifespan heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 2008;112:4284.
62. Mock DM, Lankford GL, Widness JA, Burmeister LF, Kahn D, Strauss RG. RBCs labeled at two biotin densities permit simultaneous and repeated measurements of circulating RBC volume. Transfusion 2004;44:431-437.
63. Muller HG, Wang JL, Carey JR, et al. Demographic window to aging in the wild: Constructing life tables and estimating survival functions from marked individuals of unknown age. Aging Cell 2004;3:125-131.
64. Lindsell CJ, Franco RS, Smith EP, Joiner CH, Cohen RM. A method for the continuous calculation of the age of labeled red blood cells. Am J Hematol 2008;83:454-457.
65. Cohen RM, Ciraolo P, Palascak MB, et al. Red blood cell (RBC) survival differences among hematologically normal people with diabetes (DM) make a clinically important difference in HbA1c. Diabetes 2007;56(suppl 1):A116 (Abstract).
66. Solanki DL, McCurdy PR, Cuttitta FF, Schechter GP. Hemolysis in sickle cell disease as measured by endogenous carbon monoxide production. A preliminary report. Am J Clin Pathol 1988;89:221-225.
67. Sayinalp S, Sozen T, Usman A, Dundar S. Investigation of the effect of poorly controlled diabetes mellitus on erythrocyte life. J Diabetes Complications 1995;9:190-193.
68. Kean LS, Brown LE, Nichols JW, Mohandas N, Archer DR, Hsu LL. Comparison of mechanisms of anemia in mice with sickle cell disease and β-thalassemia: Peripheral destruction, ineffective erythropoiesis, and phospholipid scramblase- mediated phosphatidylserine exposure. Exp Hematol 2002;30:394-402.
69. de Jong K, Emerson RK, Butler J, Bastacky J, Mohandas N, Kuypers FA. Short survival of phosphatidylserine-exposing red blood cells in murine sickle cell anemia. Blood 2001;98:1577-1584.
70. Nuttall FQ, Gannon MC, Swaim WR, Adams MJ. Stability over time of glycohemoglobin, glucose, and red blood cell survival in hematologically stable people without diabetes. Metabolism 2004;53:1399-1404.
71. Virtue MA, Furne JK, Nuttall FQ, Levitt MD. Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care 2004;27:931-935.
72. Peterson CM, Jones RL, Koenig RJ, Melvin ET, Lehrman ML. Reversible hematologic sequelae of diabetes mellitus. Ann Intern Med 1977;86:425-429.
73. Dallalio G, Law E, Means RT Jr. Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations. Blood 2006;107:2702-2704.
74. Cartwright GE. The anemia of chronic disorders. Semin Hematol 1966;3:351-375.
75. Lee GR. The anemia of chronic disease. Semin Hematol 1983;20:61-80.
76. Mitlyng BL, Singh JA, Furne JK, Ruddy J, Levitt MD. Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases. Am J Hematol 2006;81:432-438.
77. Lockwood WB, Hudgens RW, Szymanski IO, Teno RA, and Gray AD. Effects of rejuvenation and frozen storage on 42-day-old AS-3 RBCs. Transfusion 2003;43:1527-1532.